27 Apr Immunotherapy tablets for dust mite allergy may reduce risk of an attack in people with moderate to severe asthma
The NPR (4/26, Shute) “Shots” blog reports that research published in JAMA indicated “immunotherapy tablets for dust mite allergy reduced the risk of an attack in people with moderate to severe asthma.” The nearly 700 participants “who completed the study had asthma that wasn’t well controlled by inhaled corticosteroids. Half of the participants took a pill made of dust-mite allergen daily, letting it dissolve under the tongue.”
On its website, ABC News (4/26, Mohney) reports that researchers “looked at 834 people in Europe who have house dust mite-related asthma that is not easily controlled with available medications.” The investigators “had some patients take a daily pill containing extract from two species of dust mites and others take a placebo.” Of the nearly 700 participants “who completed the study, researchers found that that those who took the pill containing dust mites were at reduced risk of moderate or severe asthma reactions compared to those on a placebo.” MedPage Today (4/26, Boyles) also covers the story.
Source:
http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016042701chest&r=7629040-5ffe